Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Company Info
Headquarters
Number of Employees
Revenue (in millions)
Contact Info
Visit Website
Tagline
Overview
Company Services
Site Information
Contributors
Contributions
Future of the Industry
What key indicators do you look at to predict the future of this industry?
PAO-10-022--RT-02
Sustainability
What is your plan to build a more sustainable business practice in the coming years?
PAO-10-022--RT-01
Engineering
CRB Welcomes Veteran Engineering Leader as New Senior Director of Client Services for SlateXpace
PR-M04-22-02
New Leadership
CRB Announces Courtney Holt as New General Counsel
PR-M02-22-16
Leadership
CRB Expands Board-Level Leadership Team
PR-M07-21-09
Leadership
Alan Jones Returns to CRB as Vice President of Business Development
PR-M06-21-014
Engineering
Integrated Design and Engineering: Focused on the End Goal
PAO-M03-20-CL-001
Isolators
Isolator Design for Cell Therapy Facilities
PAP-Q3-19-CL-009
Facility Design
Strategic Facility Planning for Cell and Gene Therapy Facilities
PAP-Q3-19-CL-009
Facility Design
Fast-Tracking Design and Construction to Save More Lives
PAP-Q4-19-CL-014
Facility Design Trends
New Trends in Tech Impacting Pharma Facility Design and Construction
PAP-Q3-19-CL-009
Water for Injection
Membrane-Based Reverse Osmosis Systems for WFI Production
PAO-NI-0719-CL-001
Lean Delivery
Reducing Waste with Lean Delivery in Facility Design and Construction
PAP-Q2-2019-CL-013
Engineering
Leveraging Operational Simulations to Design Cell Therapy Facilities
PAP-Q1-2019-CL-016
Oligonucleotides
Designing Effective Facilities to Meet the Growing Demand for Oligonucleotide Drugs
PAP-Q4-18-CL-002
Expansion
CRB Opens Second Office in Europe, Hires Bernd Müller
PR-M10-18-NI-022
Multi-Product Manufacturing
Leveraging Offsite Fabrication in the Pharma Industry
PAP-Q3-18-CL-007
Gene Therapy
Understanding the Unique Design and Engineering Needs for Gene Therapy Production
PAP-Q3-18-CL-008
OSD Facility Design
Modern OSD Facility Design Considerations for Operational Efficiency and Regulatory Compliance
PAP-Q2-18-CL-012
Appointment
Beth Brock joins CRB’s Kansas City Office as Pharmaceutical Process Engineer
PR-M03-18-NI-069
Innovation
Death to Cleanrooms in Biopharmaceutical Manufacturing
PAP-Q1-18-CL-006
Cell and Gene Therapy
Segregation in the Design of Gene Therapy Manufacturing Facilities
PAP-Q4-17-CL-002
Facility
Oral Solid Dose Manufacturing Efficiency is Driving New Attention to Plant Design
PAP-Q3-17-CL-002
Facility
Adopting for Flexibility Overseas and at Home
PTV-M06-17-BIO-011
Facility Maintenance
CRB on the Road to BIO: Making Your Facility a Future Facility
PTV-M06-17-CL-007
Equipment
Fit Biopharmaceutical Facilities: A Predictive Maintenance Approach
PAP-Q2-17-CL-010
Equipment
A Fill Line Is More Than Just a Fill Line: Incorporating What’s Hidden in Facilities
PTV-M01-17-IN-015
Manufacturing
Facilities for the Future
PTV-M01-17-NS-012